PFE
Pfizer Inc.
- Free cash flow, 2025
- $9.1B
- YoY, 2025
- −7.7%
- 5-year CAGR
- −5.7%
- 10-year CAGR
- −3.7%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $9.1B | −7.7% |
| 2024 | $9.8B | +105.2% |
| 2023 | $4.8B | −81.6% |
| 2022 | $26.0B | −12.8% |
| 2021 | $29.9B | +145.3% |
| 2020 | $12.2B | +15.5% |
| 2019 | $10.5B | −23.8% |
| 2018 | $13.8B | −6.8% |
| 2017 | $14.8B | +3.3% |
| 2016 | $14.4B | +8.1% |
| 2015 | $13.3B | −16.3% |
| 2014 | $15.9B | −3.6% |
| 2013 | $16.5B | +6.9% |
| 2012 | $15.4B | −17.0% |
| 2011 | $18.6B | +86.9% |
| 2010 | $9.9B | −35.4% |
| 2009 | $15.4B | −7.0% |
| 2008 | $16.5B | +44.1% |
| 2007 | $11.5B | — |